Advertisement
Canada markets closed
  • S&P/TSX

    22,814.81
    +206.78 (+0.91%)
     
  • S&P 500

    5,459.10
    +59.88 (+1.11%)
     
  • DOW

    40,589.34
    +654.27 (+1.64%)
     
  • CAD/USD

    0.7230
    -0.0005 (-0.07%)
     
  • CRUDE OIL

    76.44
    -1.84 (-2.35%)
     
  • Bitcoin CAD

    93,782.91
    +1,062.49 (+1.15%)
     
  • CMC Crypto 200

    1,371.50
    +40.89 (+3.07%)
     
  • GOLD FUTURES

    2,385.70
    +32.20 (+1.37%)
     
  • RUSSELL 2000

    2,260.07
    +37.09 (+1.67%)
     
  • 10-Yr Bond

    4.2000
    -0.0560 (-1.32%)
     
  • NASDAQ

    17,357.88
    +176.16 (+1.03%)
     
  • VOLATILITY

    16.39
    -2.07 (-11.21%)
     
  • FTSE

    8,285.71
    +99.36 (+1.21%)
     
  • NIKKEI 225

    37,667.41
    -202.10 (-0.53%)
     
  • CAD/EUR

    0.6654
    -0.0013 (-0.19%)
     

2 TSX Growth Stocks Set Up for Outsized Gains in 2024

Redwood trees stretch up to the sunlight.
Source: Getty Images

Written by Adam Othman at The Motley Fool Canada

Canadian growth stocks have the potential to grow their financials at a faster pace than the broader stock market can offer, offering a greater potential for returns compared to the rest. That said, the higher growth potential comes with a greater degree of capital risk.

To deliver growth faster than others, these companies also require more capital to fund their initiatives to achieve those goals. Thus, they also trade at higher-than-normal valuations.

If you are an investor with a higher risk tolerance, you might be better suited to investing in these companies. For conservative investors, the risk of losing a lot of the money invested in the stock market is not a promising picture.

ADVERTISEMENT

Suppose you have a well-balanced portfolio and are willing to take a few risks in the stock market to capture the potential for significant wealth growth. In that case, I will discuss two TSX growth stocks you should keep on your radar.

Nuvei

Nuvei Corp. (TSX:NVEI) is a $4.9 billion market capitalization payments processing company headquartered in Montreal. The company offers a valuable service to businesses worldwide through its payment solutions.

Besides its secure payment gateway services, Nuvei also offers security and risk management, recurring and subscription billing, multicurrency pricing, dynamic currency conversion, and ACH payment processing services.

As digital payment solutions keep increasing in popularity, Nuvei remains in pole position to grow along with the demand. The fintech is also expanding its addressable market by forging partnerships and launching new products and futures that can boost its earnings for years to come.

As of this writing, Nuvei stock trades for $34.96 per share. While up by 54.4% from its August 2023 levels, it still trades for a massive 80% discount from its September 2021 all-time high.

WELL Health Technologies

WELL Health Technologies Corp. (TSX:WELL) is a $948.5 million market capitalization telehealth company headquartered in Vancouver.

The multichannel digital health technology company is also the largest owner and operator of outpatient health clinics in Canada. The company owns and operates several primary healthcare facilities in Canada and the US, while offering EMR services to clinics and doctors throughout Canada.

The pandemic saw a massive surge in demand for telehealth services. Being the only tech company in the healthcare sector in Canada, WELL Health saw a massive boost in its share prices. After the rapid growth, the tech sector meltdown and move into a post-pandemic era saw it fall out of favour with investors.

The company is currently undertaking cost-optimization initiatives to improve its financials. It has also signed agreements to acquire several clinics through mergers and acquisitions and absorption program deals. These initiatives make the management confident about a significant improvement in its revenue in 2024 and beyond.

As of this writing, WELL Health stock trades for $3.95 per share. Down by 55% from its February 2021 all-time highs, it could be an astute move to add this stock to your portfolio before a potential recovery.

  • We just revealed five stocks as “best buys” this month … join Stock Advisor Canada to find out if WELL Health made the list!

Foolish takeaway

Amid the boom in the industry after the stock market began recovering from the pandemic-induced sell-off frenzy, Canadian tech stocks became synonymous with growth stocks. For many, tech stocks became almost infallible assets to consider for multi-bagger returns. However, the meltdown due to several factors and bubble bursting put things into perspective.

While investors are no longer as afraid of indulging in Canadian tech stock investing, most know better than to go all-in with these risky investments. Despite the risk associated with these growth stocks, it is clear that Canadian tech stocks offer substantial wealth growth potential.

If you have the investment capital to spare and are willing to take the risk, adding Nuvei stock and WELL Health stock to your self-directed portfolio might turn out to be a bet well worth your dime in the long run.

The post 2 TSX Growth Stocks Set Up for Outsized Gains in 2024 appeared first on The Motley Fool Canada.

Should you invest $1,000 in Nuvei right now?

Before you buy stock in Nuvei, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nuvei wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $17,988!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 35 percentage points since 2013*.

See the 10 stocks * Returns as of 1/24/24

More reading

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nuvei. The Motley Fool has a disclosure policy.

2024